Delivery Order SPE2DB22D1106-SPE2DB25FEUA9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,899.74 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 150 mg tablets (60-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract action under...
- The Defense Logistics Agency awarded a delivery order valued at $2,944.08 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 100 mg tablets (60-count packages) with a completion date of August 11, 2025. This competitively awarded, non-set-aside contract operates under a firm fixed price arrangement and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $6,441.19 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units). This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement extending through December 2026. The order will be fulfilled from the contractor's...
- This delivery order, awarded on June 4, 2025, by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp, provides for the supply of Nucynta ER 150 mg tablets (60-count units) with a ceiling value of $2,849.58 under firm fixed pricing. The order is not set-aside and represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. AmerisourceBergen Drug Corp, a major healthcare solutions provider and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Nucynta ER 150 mg tablets (60-count units) with a ceiling value of $1,110.11. This firm fixed-price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be performed at AmerisourceBergen's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Nucynta ER 150 mg tablets (60-count units) with a contract ceiling value of $4,749.30. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through an open procurement process. The order is scheduled for ultimate completion on August 21, 2025, and will be fulfilled from AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta ER 50 mg tablets (60-count) under a firm fixed-price contract valued at $1,194.33. The award, issued on August 18, 2025, represents a non-set-aside competitive award with an ultimate completion date of August 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,367.15 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 150 mg tablets (60-count) on August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at the awardee's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. The order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $1,562.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Nucynta ER 150 mg tablets (60-count units). This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The prime vendor contract serves as a comprehensive global pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Nucynta ER 50 mg tablets (60-count), with a contract ceiling value of $1,398.37. This is a firm fixed-price delivery order with no set-aside designation, demonstrating competitive award to the contractor. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery order is...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEUA9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Nucynta ER 50 mg tablets (60-count units) valued at $1,592.44. This is a firm fixed-price, non-set-aside delivery order with a completion deadline of June 20, 2025, and performance will be executed from the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999 prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceuticals and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates consistent capability to deliver diverse pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains, all awarded through competitive procurement processes. This specific delivery order for pain management medication supports the DLA Medical Supply Chain's mission to sustain military healthcare readiness.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 6/18/25 |